At the threshold of clinical trials: The status of the Finnish BNCT project

Markus Färkkilä, Sauli Savolainen, Merja Kallio, Iiro Auterinen, Martti Kulvik, Pekka Hiismäki, Marjatta Snellman, Carita Aschan, Judit Benczik, Juha Jääskeläinen, Eija Järviluoma, Heikki Joensuu, Leena Kankaanranta, Mika Kortesniemi, Antti Kosunen, Petri Kotiluoto, Juha Laakso, Seppo Pakkala, Merja Rasilainen, Seppo SalmenhaaraTiina Seppälä, Tom Serén, Marika Suominen, Mikko Tenhunen, Matti Toivonen, Leena Tähtinen, Jyrki Vähätalo

    Research output: Chapter in Book/Report/Conference proceedingConference article in proceedingsScientificpeer-review

    Abstract

    The aim of the Finnish BNCT-project is to start BNC-treatments of malignant brain tumors. The first clinical trial is planned to start in early 1999 at the treatment facility of the 250kW FiR 1 TRIGA research reactor. Excellent patient treatment facilities have been built at the reactor which is located only 5 km from the Helsinki University Central Hospital making the treatment facility very easy to reach.
    Original languageEnglish
    Title of host publicationFrontiers in Neutron Capture Therapy
    EditorsM. Frederick Hawthorne, Kenneth Shelly, Richard J. Wiersema
    PublisherSpringer
    Chapter14
    Pages129-131
    Volume1
    ISBN (Electronic)978-1-4615-1285-1
    ISBN (Print)978-1-4613-5478-9
    DOIs
    Publication statusPublished - 2001
    MoE publication typeA4 Article in a conference publication
    Event8th International Symposium on Neutron Capture Therapy for Cancer - Los Angeles, United States
    Duration: 13 Aug 199818 Aug 1998

    Conference

    Conference8th International Symposium on Neutron Capture Therapy for Cancer
    CountryUnited States
    CityLos Angeles
    Period13/08/9818/08/98

    Fingerprint Dive into the research topics of 'At the threshold of clinical trials: The status of the Finnish BNCT project'. Together they form a unique fingerprint.

    Cite this